Crop Life Science Ltd.

Crop Life Science Ltd.

NNSE:CLSL
74.45
INR
+3.50
(+4.93%)
702.74MMarket Cap
Crop Life Science Ltd.
NSE:CLSL
(National Stock Exchange of India)

Recent

price

74.45

P/E

ratio

- -

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2023
2024
2025
2026
TTM
INR
78.81
69.38
59.48
- -
76.56
115.73
116.94
120.65
- -
Revenue per Share
1.88
2.16
1.64
- -
2.38
3.51
3.44
3.87
- -
Basic EPS, GAAP
1.03
0.51
-2.63
- -
-1.6
-9.2
-3.15
-5.57
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
17.33
19.34
21.01
23.56
23.66
41.85
45.19
49.15
49.15
Book Value per Share
17
19.08
20.8
23.37
23.45
40.22
43.69
47.74
47.74
Tangible Book Value per Share
17
17
17
17
17
17
17
17
17
Basic Weighted Avg Shares
1,351
1,189
1,019
- -
1,312
1,984
2,004
2,068
- -
Sales/Revenue/Turnover
4.82
5.6
5.36
- -
6.36
4.75
5.47
5.87
- -
Operating Margin (%)
18
25
23
- -
37
44
48
49
- -
Depreciation Expense
32
37
28
- -
41
60
59
66
- -
Net Income, GAAP
29.59
24.78
25.33
- -
27.26
25.79
28.15
29.65
- -
Effective Tax Rate (%)
2.39
3.12
2.76
- -
3.1
3.03
2.94
3.21
- -
Profit Margin (%)
196
248
261
308
308
471
494
628
628
Working Capital
13
36
21
59
57
90
55
45
45
LT Debt
297
331
360
404
406
759
813
880
880
Total Equity
- -
10.13
7.66
- -
9.07
8.35
6.71
6.4
- -
Return on Invested Capital (%)
- -
10.37
7.85
- -
9.32
9.14
7.88
7.6
- -
Return on Capital (%)
- -
11.79
8.14
- -
10.06
10.72
7.9
8.21
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
388
530
521
LT Borrowings
28
30
24
LT Finance Leases
27
25
21
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
17
17
17
Market Capitalization
874
943
703

Working Capital

INR

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
1,422
1,867
1,767
Cash, Cash Equivalents & STI
9
26
35
Accounts Receivable, Net
693
810
741
Inventories
489
695
706
Total Current Liabilities
928
1,280
1,138
Payables & Accruals
- -
- -
- -
ST Debt
388
530
521
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
23.01%
8.18%
Free Cash Flow
- -
- -
76.9%
Net Income, GAAP
- -
- -
12.62%
Sales/Revenue/Turnover
- -
- -
3.18%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1,984
2025
- -
- -
2,004
2026
- -
- -
2,068

Semi-annual Earnings Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3.51
2025
- -
- -
3.44
2026
- -
- -
3.87

Semi-annual Dividends Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Business
Crop Life Science Ltd (CLSL.NS) manufactures crop protection chemicals and allied agricultural products. The company produces insecticides, fungicides, herbicides, weedicides, micro fertilizers, new generation organic bio-stimulants, bio-fertilizers, bio-pesticides, plant growth regulators, and soil plant health products. CLSL operates ISO 9001:2015 and ISO 14001:2004 certified manufacturing facilities located in Ankleshwar and Vadodara, Gujarat, India, with a marketing setup in Baroda facilitating direct farmer communication. Incorporated on May 24, 2006, and headquartered in Vadodara, India, the company serves domestic markets across states including Gujarat, Maharashtra, Uttar Pradesh, Madhya Pradesh, Bihar, West Bengal, and Chhattisgarh through approximately 2,200 distributor and wholesaler outlets; it also exports to countries such as Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Subsidiaries include Hetban Spechem Limited, with a technical-grade agrochemical manufacturing site in Dahej, Gujarat, and CLSL Pack Science Private Limited, operating a facility in POR Industrial Park, Vadodara. In recent developments, CLSL fully utilized its IPO proceeds of Rs. 26.73 crore by March 31, 2025, announced audited FY25 financial results in May 2025 showing revenue of Rs. 201 crore and profit of Rs. 7 crore, appointed A R Shaikh & Co. as internal auditor and M/s. Ranjit & Associates as secretarial auditor for FY2025-26 in July and August 2025, respectively, scheduled its AGM for September 26, 2025, to approve FY2024-25 accounts and revise managerial remuneration, and increased equity capital from Rs. 12 crore to Rs. 17 crore between FY2024 and FY2025.